MacroGenics acquires Eliance

Immunotherapeutic company MacroGenics (Rockville, Md.) acquired vaccine play Eliance (Dallas, Texas) for an undisclosed amount of stock. As part of the acquisition, MacroGenics established a licensing deal and alliance to enhance discovery and development of immunotherapeutics with The University of Texas Southwestern Medical Center at Dallas, where Eliance's bacterial and viral screening technology originated. ...